Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.

about

Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.

P2860

Q47402625-FA4DB5C0-3855-4293-B40B-1A9FF1679AAE

P2860

Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.

Item

http://www.wikidata.org/entity/Q41195879

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Randomized controlled trial of ...... the multinational MATEO study.

@en

type

Item

label

Randomized controlled trial of ...... the multinational MATEO study.

@en

prefLabel

Randomized controlled trial of ...... the multinational MATEO study.

@en

P1476

Randomized controlled trial of ...... the multinational MATEO study.

@en

P2093

Dirk Jaeger

http://www.w3.org/2001/XMLSchema#string

Florian Lordick

http://www.w3.org/2001/XMLSchema#string

Georg-Martin Haag

http://www.w3.org/2001/XMLSchema#string

Gertraud Stocker

http://www.w3.org/2001/XMLSchema#string

Julia Quidde

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy for advanced gastric cancer

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.

P2888

s12885-017-3497-9

P304

509

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-017-3497-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090935738

http://www.w3.org/2001/XMLSchema#string

P698

28760152

http://www.w3.org/2001/XMLSchema#string

P932

5537937

http://www.w3.org/2001/XMLSchema#string

Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.

about

P2860

P2860

Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932